Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | RO7172508 |
| Synonyms | |
| Therapy Description |
RO7172508 (RG6123) targets the tumor specific antigen, carcinoembryonic antigen (CEA), to induce cell death (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| RO7172508 | RG6123|RG-6123|RG 6123|RO-7172508|RO 7172508 | RO7172508 (RG6123) targets the tumor specific antigen, carcinoembryonic antigen (CEA), to induce cell death (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03539484 | Phase I | RO7172508 | A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors | Terminated | ESP | DNK | CAN | BEL | 0 |